Teladoc shareholders approve 6.85M share increase for incentive plan; say-on-pay passes with 26.6% against

Teladoc Health, Inc.

Shareholders approved amendment to 2023 Incentive Award Plan, increasing authorized shares by 6,850,000.
All nine director nominees elected; David B. Snow Jr. received 19.9M against (23.9% against) and Kenneth Paulus received 10.9M against (13.1% against).
Advisory vote on executive compensation passed: 61.2M for, 22.2M against (26.6% against).
Ratification of Ernst & Young as independent auditor for FY2025 approved with 119.9M votes for.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.